Feature Channels: Respiratory Diseases and Disorders

Filters close
6-Mar-2017 10:05 AM EST
New Method Rescues Donor Organs to Save Lives
Columbia University School of Engineering and Applied Science

Researchers from Columbia Engineering and Columbia University Medical Center have—for the first time—maintained a fully functional lung outside the body for several days. They designed the cross-circulation platform that maintained the viability and function of the donor lung and the stability of the recipient over 36-56 hours, used the advanced support system to fully recover the functionality of lungs injured by ischemia and made them suitable for transplant. (Nature Biomedical Engineering 3/6)

3-Mar-2017 8:00 AM EST
Mouse Arrest
Johns Hopkins Medicine

The results of a new study reveal that a professional pest management intervention was no better in decreasing asthma symptoms in children allergic to mice than teaching families how to reduce the level of allergens shed by mice in the home on their own.

Released: 1-Mar-2017 10:00 AM EST
Exploring the Cause of Chronic Lung Transplant Rejection, in a Quest to Stop It
Michigan Medicine - University of Michigan

A new paper from Michigan Medicine researchers examined the scarring process in transplanted lungs in hopes of identifying novel therapies to stop scarring before it starts.

Released: 27-Feb-2017 12:05 PM EST
Limiting Lung Cancer’s Spread and Growth in the Brain
Yale Cancer Center/Smilow Cancer Hospital

Led by associate professor of pathology and Yale Cancer Center member Don Nguyen, PhD, the researchers analyzed RNA from patients with disease that was limited to the lungs as well as cancers that had spread.

21-Feb-2017 11:30 AM EST
Mayo Clinic Researchers Discover Link Between Aging, Devastating Lung Disease
Mayo Clinic

A Mayo Clinic study has shown evidence linking the biology of aging with idiopathic pulmonary fibrosis, a disease that impairs lung function and causes shortness of breath, fatigue, declining quality of life, and, ultimately, death. Researchers believe that these findings, which appear today in Nature Communications, are the next step toward a possible therapy for individuals suffering from idiopathic pulmonary fibrosis.

Released: 22-Feb-2017 2:05 PM EST
UChicago Researchers Offer Solutions for Childhood Asthma Disparities
University of Chicago Medical Center

Lingering disparities in childhood asthma should be addressed with additional research and quality improvement efforts that work in concert to improve children’s health, according to a new paper published today by researchers from the University of Chicago Medicine in the medical journal Pediatrics.

Released: 21-Feb-2017 5:05 PM EST
New U-M Study Shows How Bacteria Get Into the Lungs; Findings Could Help Disease Research
Michigan Medicine - University of Michigan

Human lungs contain many bacteria, which make up a unique microbiome. New research pinpoints just how they get there, and opens the door to more research on what happens to them – and our bodies – as a result.

Released: 17-Feb-2017 7:05 PM EST
Penn Team Tracks Rare T Cells in Blood to Better Understand Annual Flu Vaccine
Perelman School of Medicine at the University of Pennsylvania

A team has found a way to identify the small population of circulating helper T cells present in the blood after an annual flu vaccine to monitor their contribution to antibody strength. A technique that identifies these helper immune cells could inform future vaccine design, especially for vulnerable populations.

Released: 17-Feb-2017 10:05 AM EST
Yeast Found in Babies’ Guts Increases Risk of Asthma
University of British Columbia

University of British Columbia microbiologists have found a yeast in the gut of new babies in Ecuador that appears to be a strong predictor that they will develop asthma in childhood. The new research furthers our understanding of the role microscopic organisms play in our overall health.

Released: 16-Feb-2017 12:00 AM EST
Attacking the Flu by Hijacking Infected Cells
Rutgers University

They’re called TIPs and their task would be to infiltrate and outcompete influenza, HIV, Ebola and other viruses. Soon, Rutgers’ Laura Fabris will play a key role in a project aimed at designing TIPs – therapeutic interfering particles to defuse the flu. For the first time in virology, Fabris and her team will use imaging tools with gold nanoparticles to monitor mutations in the influenza virus, with unprecedented sensitivity, when it enters cells. Fabris will soon receive a $820,000 grant from the Defense Advanced Research Projects Agency (DARPA). It’s part of a four-year, $5.2 million INTERfering and Co-Evolving Prevention and Therapy (INTERCEPT) program.

   
8-Feb-2017 2:05 PM EST
Smoking Cessation Counseling Successful When Paired with Lung Cancer Screening
Lombardi Comprehensive Cancer Center at Georgetown University

The first successful randomized trial of its kind provides preliminary evidence that telephone-based smoking cessation counseling given to smokers shortly after undergoing lung cancer screening can be effective at helping people stop smoking.

Released: 14-Feb-2017 9:00 AM EST
Johns Hopkins Kimmel Cancer Center Names Benjamin Levy to Lead Medical Oncology Program at Sibley
Johns Hopkins Medicine

Lung cancer specialist Benjamin Levy, M.D., has been named the new clinical director of medical oncology and medical director of thoracic oncology for the Johns Hopkins Kimmel Cancer Center at Sibley Memorial Hospital in northwest Washington, D.C.

Released: 10-Feb-2017 5:05 AM EST
Whooping Cough on the Rise in Michigan
Children's Hospital of Michigan

The Michigan Department of Health and Human Services and Oakland County Health Division have issued a health advisory.

7-Feb-2017 4:05 PM EST
Chinese Air Pollution Linked to Respiratory and Cardiovascular Deaths
American Thoracic Society (ATS)

In the largest epidemiological study conducted in the developing world, researchers found that as exposures to fine particulate air pollution in 272 Chinese cities increase, so do deaths from cardiovascular and respiratory diseases.

Released: 9-Feb-2017 8:00 AM EST
TSF Awards $655,000 in Cardiothoracic Surgery Grants
The Society of Thoracic Surgeons

The Thoracic Surgery Foundation (TSF) has announced 16 new grants in support of research and education programs in cardiothoracic surgery.

7-Feb-2017 9:45 AM EST
Excessive Antibiotic Use in Newborns Can Permanently Damage Lungs’ Defenses
Cincinnati Children's Hospital Medical Center

Doctors have long understood that antibiotics that protect infants from infection also can disrupt the normal growth of their gut bacteria. However, a new study reveals that the consequences of routine antibiotic use may be deeper and longer lasting than expected. The study, published Feb. 8 in Science Translational Medicine, shows that short-term disruption of gut bacteria makes infant mice more likely to develop pneumonia. It also makes them more likely to die from it.

Released: 8-Feb-2017 11:05 AM EST
Immunotherapy May Need to Have Its Own Value Model
Yale Cancer Center/Smilow Cancer Hospital

Immunotherapy has been a game changer for the oncology field, but typical models used to assess the value of cancer treatments don’t take into account the unique characteristics of this therapy, according to experts at the 2016 annual meeting of the Society for Immunotherapy of Cancer (SITC).

7-Feb-2017 2:05 PM EST
A “Release and Kill” Strategy May Aid Treatment of Tuberculosis
University of Alabama at Birmingham

In a proof-of-concept experiment, researchers were able to specifically force M. tuberculosis-infected macrophages into programmed cell death called apoptosis, thereby releasing the sheltered M. tuberculosis bacteria from the macrophage and expose them to a lethal dose of rifampicin antibiotic.

Released: 7-Feb-2017 10:00 AM EST
Mixing Opioids and Alcohol May Increase Likelihood of Dangerous Respiratory Complication, Especially in the Elderly, Study Finds
American Society of Anesthesiologists (ASA)

Taking one oxycodone tablet together with even a modest amount of alcohol increases the risk of a potentially life-threatening side effect known as respiratory depression, which causes breathing to become extremely shallow or stop altogether, reports a study published in the Online First edition of Anesthesiology.

6-Feb-2017 10:05 AM EST
Researchers Use Tiny 3D Spheres to Combat Tuberculosis
University of Southampton

Southampton have developed a new 3D system to study human infection in the laboratory.

Released: 6-Feb-2017 12:05 PM EST
Yale Study: 1 in 4 Teen E-Cigarette Users Have Tried 'Dripping'
Yale Cancer Center/Smilow Cancer Hospital

Yale researchers found in a study that one in four high schoolers who use electronic cigarettes are inhaling vapors produced by dripping e-liquids directly onto heating coils, instead of inhaling from the e-cigarette mouthpiece, possibly increasing exposure to toxins and nicotine.

6-Feb-2017 11:00 AM EST
UNC Researchers Find New Potential Route to Treat Asthma
University of North Carolina Health Care System

Researchers at the UNC School of Medicine believe they have isolated a protein that, when missing or depleted, can cause airway constriction, production of mucus, chest tightness, and difficulty breathing for the 334 million people worldwide who suffer from asthma.

Released: 3-Feb-2017 4:00 PM EST
Penn Researchers Identify Missing Link for Fighting Viral Pneumonia
Perelman School of Medicine at the University of Pennsylvania

According to the Centers for Disease Control, respiratory syncytial virus (RSV) causes about 60,000 hospitalizations of children aged 0 to four, and nearly 200,000 hospitalizations and 14,000 deaths among adults 65 and older. However, there are virtually no vaccines or treatments for these infections. In a study published online ahead of print in PLoS Pathogens, researchers from the Perelman School of Medicine at the University of Pennsylvania and the University of Pennsylvania School of Veterinary Medicine found evidence that the cytokine, Interleukin 27 (IL-27), may be the key to fighting and treating these infections.

Released: 3-Feb-2017 5:00 AM EST
Texas Biomed Names Larry Schlesinger, M.D. As President/CEO
Texas Biomedical Research Institute

Texas Biomedical Research Institute announced that its Board of Trustees has named Dr. Larry Schlesinger as the Institute’s new President and CEO. Dr. Schlesinger will take the helm of Texas Biomed effective May 31, 2017.

31-Jan-2017 12:05 PM EST
Monoclonal Antibody Given to Preterm Babies May Reduce Wheeze Later
American Thoracic Society (ATS)

Preterm babies given the monoclonal antibody palivizumab to prevent respiratory syncytial virus (RSV) also appear less likely to develop recurrent wheeze, at least until the age of six, according to new research published online, ahead of print in the American Thoracic Society’s American Journal of Respiratory and Critical Medicine.

Released: 2-Feb-2017 12:30 PM EST
Child Health Institute of New Jersey Awarded $5 Million Grant From the Robert Wood Johnson Foundation
Rutgers Robert Wood Johnson Medical School

The Child Health Institute of New Jersey has been awarded a $5 million grant from the Robert Wood Johnson Foundation, which will expand and enhance its core mission to improve children’s health through the scientific study of pediatric illnesses, including asthma, type 1 diabetes and autism.

Released: 1-Feb-2017 10:05 AM EST
Breathing Molecule Discovered: Vital to Treating Respiratory Conditions
University of Warwick

Respiratory conditions could be better targeted and treated, thanks to the discovery of the vital molecule which regulates breathing – according to research by the University of Warwick.

Released: 30-Jan-2017 4:05 PM EST
GOLD 2017 Report Released with New Recommendations on Assessing COPD, Drug Escalation Strategies, Non-Pharmacologic Treatments and Comorbidities
American Thoracic Society (ATS)

The Global Initiative for the Diagnosis, Management and Prevention of Chronic Obstructive Lung Disease (GOLD) has published its 2017 report online, ahead of print in the American Thoracic Society’s American Journal of Respiratory and Critical Care Medicine.

Released: 30-Jan-2017 8:00 AM EST
Can Big Data Help Cancer Patients Avoid ER Visits?
Perelman School of Medicine at the University of Pennsylvania

What if doctors could look into a crystal ball and predict which of their patients might be at risk of getting sick enough to go to the emergency room? For at least one group of patients, that’s exactly what researchers at Penn Medicine are trying to do.

Released: 26-Jan-2017 1:30 PM EST
GSG III Foundation Pledges More Than $1 Million for New Research Program at UofL to Combat Inflammatory Lung Disease
University of Louisville

A pledge from the GSG III Foundation, Inc., will allow for the creation of the Gibbs Lung Research Program. The program will focus on developing better models for studying lung inflammation and allow for new research into causes and potential therapies for lung diseases that affect millions of Americans.

Released: 26-Jan-2017 9:05 AM EST
Precision Medicine: UAB Study Creates ‘Mini-Lung’ to Study Effect of Pulmonary Fibrosis Drugs
University of Alabama at Birmingham

Pulmospheres, three dimensional multicellular spheroids composed of lung cells from individual patients, were shown to be effective in predicting the efficacy of medications for idiopathic pulmonary fibrosis, according to findings from UAB presented today in JCI Insight.

Released: 25-Jan-2017 3:05 PM EST
Breathe Easy as You Plan an Allergy- and Asthma-Free Valentine’s Day
American College of Allergy, Asthma and Immunology (ACAAI)

If you want to plan the perfect Valentine’s Day for your sweetheart, keep their allergies and asthma in mind.

Released: 25-Jan-2017 10:00 AM EST
Living Without Lungs for Six Day Saves a Mom’s Life
University Health Network (UHN)

In a bold and very challenging move, thoracic surgeons at Toronto General Hospital, University Health Network removed severely infected lungs from a dying mom, keeping her alive without lungs for six days, so that she could recover enough to receive a life-saving lung transplant.

Released: 24-Jan-2017 5:05 PM EST
New Tuberculosis Therapy Could Be More Potent Than Current Treatments
University of California, Los Angeles (UCLA), Health Sciences

Researchers have devised a potential drug regimen for tuberculosis that could cut the treatment time by up to 75 percent, while simultaneously reducing the risk that patients could develop drug-resistant TB.

19-Jan-2017 7:00 AM EST
Lung Cancer Screening Programs in Communities Are Vital, but Challenges Exist
The Society of Thoracic Surgeons

Implementing lung cancer screening as a high-quality preventive health service in a community setting is feasible, but comes with several key challenges, according to a scientific presentation at the 53rd Annual Meeting of The Society of Thoracic Surgeons.

20-Jan-2017 1:05 PM EST
Regulating Gasotransmitters Could Improve Care for Sleep Apnea
University of Chicago Medical Center

Unbalanced signaling by two molecules that regulate breathing leads to sleep apnea in mice and rats. Injection of a substance that reduces production of one of those signals can prevent apneas. This approach may help people suffering from multiple forms of sleep-disordered breathing.

17-Jan-2017 10:30 AM EST
Children with Asthma May Be at Higher Obesity Risk
American Thoracic Society (ATS)

Children with asthma may be more likely to become obese later in childhood or in adolescence, according to new research published online ahead of print in the American Thoracic Society’s American Journal of Respiratory and Critical Care Medicine.

Released: 19-Jan-2017 3:05 PM EST
Molecular Subgroups of Non-Small Cell Lung Cancer Predict Tumor Behavior, Reveal Treatment Targets
Sbarro Health Research Organization (SHRO)

EGFR mutations is associated with a longer median overall survival (almost double) compared with those without EGFR mutations when treated with specific targeted agents.

Released: 19-Jan-2017 1:05 PM EST
Mayo Researchers Identify Mechanism of Oncogene Action in Lung Cancer
Mayo Clinic

Researchers at Mayo Clinic have identified a genetic promoter of cancer that drives a major form of lung cancer. In a new paper published this week in Cancer Cell, Mayo Clinic researchers provide genetic evidence that Ect2 drives lung adenocarcinoma tumor formation.

Released: 13-Jan-2017 10:05 AM EST
Karen Glanz, PhD, MPH, Appointed to Advisory Council for the National Heart, Lung and Blood Institute
University of Pennsylvania School of Nursing

The Council advises on matters relating to the cause, prevention, diagnosis and treatment of heart, blood vessel, lung and blood diseases; the use of blood and blood products and the management of blood resources; and on sleep disorders.

12-Jan-2017 5:05 PM EST
Nigeria: Clean-Burning Stoves Improve Health for New Mothers
University of Chicago Medical Center

In a clinical trial in Nigeria that replaced biomass and kerosene cookstoves with clean-burning ethanol stoves, researchers were able to reduce by two-thirds the risk of high blood pressure and cardiovascular disease in pregnant women.

5-Jan-2017 2:05 PM EST
Huntsman Cancer Institute Research Holds Promise for Personalized Lung Cancer Treatments
University of Utah Health

New research from scientists at Huntsman Cancer Institute (HCI) at the University of Utah uncovered distinct types of tumors within small cell lung cancer that look and act differently from one another. Scientists also identified a targeted drug combination that worked well with one specific tumor type. The study was published today in Cancer Cell. The findings suggest small cell lung cancer should not be treated as a uniform disease.

Released: 10-Jan-2017 12:30 PM EST
Innovative Imaging and Surgery Used to Treat Lymphatic Condition in Adults
Children's Hospital of Philadelphia

Researchers who developed a safe and effective procedure to remove thick clogs in children’s airways are now reporting similar success in adult patients. In this rare condition, called plastic bronchitis, patients develop thick, caulk-like casts that form in the branching paths of their airways.

Released: 6-Jan-2017 12:05 PM EST
Why Is Asthma Worse in Black Patients?
University of Illinois Chicago

African Americans may be less responsive to asthma treatment and more likely to die from the condition, in part, because they have a unique type of airway inflammation, according to a study led by researchers at the University of Illinois at Chicago College of Medicine. The study is one of the largest and most diverse trials conducted in the U.S. on race and asthma, with 26 percent of the patients self-identifying as African American. Researchers found that black patients were more likely to exhibit eosinophilic airway inflammation than whites, despite taking comparable doses of asthma medication, such as inhaled corticosteroids.

Released: 6-Jan-2017 10:05 AM EST
Lung Cancer Patients May Benefit From Delayed Chemotherapy After Surgery
Yale Cancer Center/Smilow Cancer Hospital

A new Yale study suggests that patients with a common form of lung cancer may still benefit from delayed chemotherapy started up to four months after surgery, according to the researchers.

Released: 5-Jan-2017 10:00 AM EST
Cancers Evade Immunotherapy by 'Discarding the Evidence' of Tumor-Specific Mutations
Johns Hopkins Medicine

Results of an initial study of tumors from patients with lung cancer or head and neck cancer suggest that the widespread acquired resistance to immunotherapy drugs known as checkpoint inhibitors may be due to the elimination of certain genetic mutations needed to enable the immune system to recognize and attack malignant cells.



close
2.09311